loader image
Saturday, October 25, 2025
94.4 F
McAllen
- Advertisement -

Governor Signs Ibogaine Treatment Research into Law

Translate to Spanish or other 102 languages!

Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. Photo: Office of The Governor
Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. Photo: Office of The Governor
- Advertisement -

AUSTIN — Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. 

“Texas is home to more veterans than any other state,” said Governor Abbott. “Many of those veterans suffer from injuries both seen and unseen. A therapy that has shown great promise in treating those conditions is ibogaine. This law authorizes a Food and Drug Administration approved clinical drug trial that will seek approval of ibogaine as a medication for the treatment of opioid use disorder and other behavioral health conditions, especially those suffered by our veterans. Texas will now lead the way in America for the evaluation of ibogaine as a potential medication that can help improve the lives of so many veterans.” 

View the Governor’s full bill signing ceremony here.

- Advertisement -

The Governor was joined at the bill signing ceremony by Speaker Dustin Burrows, Senator Tan Parker, Senator Charles Perry, and dozens of Texas supporters.

Ibogaine is a plant-based, psychoactive substance that can help treat opioid use disorder, depression, and post-traumatic stress disorder. Senate Bill 2308 allows the Texas Health and Human Services Commission to provide state matching funds for a Food and Drug Administration drug trial managed by a public university in partnership with a drug company and hospital.

Senate Bill 2308 (Parker/Harris) authorizes clinical drug trials on ibogaine to research the potential for treatment of opioid use disorder, depression, and post-traumatic stress disorder.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Donates $5,000 to TSTC Foundation for Educational Scholarships

Mega Doctor News Providing essential diagnostic, therapeutic and direct care services that support...

Common Toxin Linked to Liver Disease 

Now, a new study published in Liver International from Keck Medicine of USC reveals that tetrachloroethylene (PCE), a chemical used in dry cleaning and found in consumer products such as adhesives for arts and crafts, spot cleaners and stainless steel polish, may also be harmful to the liver.

University of Houston & DHR Health Multi-Million Dollar Medical Research & Education Center in the RGV

The University of Houston and DHR Health Hospital System today announced an agreement to establish The University of Houston Tilman J. Fertitta Family College of Medicine and DHR Health Medical Research and Education Center in the Rio Grande Valley.

Nursing Student Seizes a Second Chance at College

Motivated by the arrival of her son, South Texas College student April Pizaña found the courage to return to school and pursue a new path in Nursing. 
- Advertisement -
×